Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

05-30-2018 | Insulin | Editorial | Article

Hit early, hit hard: The EADSG insulin guidelines

Sanjay Kalra and Silver Bahendeka, East Africa Diabetes Study Group Chair, provide an overview of the latest insulin guidance developed to aid management in a challenging region, facing familiar struggles.

06-18-2018 | Diagnosis | Highlight | News

Single blood sample could be sufficient for diabetes diagnosis

Researchers studying the ARIC cohort have found that virtually all people with elevated fasting plasma glucose and glycated hemoglobin in the same blood sample went on to develop diabetes.

Barriers to insulin: Initiation in type 2 diabetes patients

Editorial Board member Lori Berard talks through the stages and challenges associated with preparing type 2 diabetes patients for insulin therapy (9:00).

Latest from across the site

06-05-2018 | Mental health | Article

Cognitive function deficits associated with long-duration type 1 diabetes and vascular complications

Musen G et al. Diabetes Care 2018: dc171955. doi: 10.2337/dc17-1955

06-05-2018 | Cardiovascular outcomes | Article

Sex-specific associations between adolescent categories of BMI with cardiovascular and non-cardiovascular mortality in midlife

Furer A et al. Cardiovasc Diabetol 2018; 17: 80. doi: 10.1186/s12933-018-0727-7

06-19-2018 | Retinopathy | Review | Article

New insights into diabetic retinopathy by OCT angiography

Liu G, Xu D, Wang F. Diabetes Res Clin Prac 2018; 142: 243–253. doi: 10.1016/j.diabres.2018.05.043

06-18-2018 | Diagnosis | Highlight | News

Single blood sample could be sufficient for diabetes diagnosis

Researchers studying the ARIC cohort have found that virtually all people with elevated fasting plasma glucose and glycated hemoglobin in the same blood sample went on to develop diabetes.

Source:

Ann Intern Med 2018; doi:10.7326/M18-0091

06-18-2018 | Dulaglutide | News

Dulaglutide feasible alternative to insulin glargine in patients with CKD

Once-weekly dulaglutide lowers glycated hemoglobin levels to a similar degree to titrated daily insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease, study findings indicate.

Source:

Lancet Diabetes Endocrinol 2018; Advance online publication

Meet our Editorial Board

Lori BerardSanjay KalraJay ShubrookProfessor John Wilding

New Content Item Meet our Advisory Board

image credits